Dendrobium Huoshanense Suppository in Rectal Cancer

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer

NCT06577194 ·Status: RECRUITING ·Phase: PHASE2

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

NCT02423226 ·Status: COMPLETED ·Phase: PHASE2

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

NCT01129700 ·Status: COMPLETED ·Phase: PHASE2

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT03573791 ·Status: RECRUITING

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

NCT01268943 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

NCT07239466 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

NCT06017583 ·Status: RECRUITING ·Phase: PHASE3

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

NCT05148767 ·Status: RECRUITING ·Phase: PHASE4

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

NCT06300489 ·Status: RECRUITING ·Phase: PHASE1

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

NCT06760520 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT07281157 ·Status: RECRUITING ·Phase: PHASE2

Action of Synbiotics on Irradiated GI Mucosa in Rectal Cancer Treatment

NCT03420443 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

NCT05799443 ·Status: UNKNOWN ·Phase: PHASE2

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

NCT04558684 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

NCT04663763 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment

NCT05897749 ·Status: RECRUITING ·Phase: PHASE4

Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy

NCT04923620 ·Status: RECRUITING

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

NCT05307198 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail

NCT06108596 ·Status: COMPLETED ·Phase: PHASE2

Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer

NCT01528683 ·Status: COMPLETED ·Phase: NA

Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer

NCT05187481 ·Status: UNKNOWN ·Phase: PHASE3

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

NCT03702985 ·Status: UNKNOWN ·Phase: PHASE2

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

NCT07090031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2